Sign In
Buy AEMD
$0.669
-0.0390 (-5.51%)
At Close: Jul 13, 2026
Second cohort findings consistent with previously reported observations; independent statistical analysis planned following completion of all three patient cohorts SAN DIEGO, July 13, 2026 /PRNewswire
Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules
09:25am, Monday, 06'th Jul 2026
SAN DIEGO, July 6, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, tod
Peer-reviewed study identifies altered extracellular vesicles in Long COVID and provides additional scientific rationale for evaluating the Hemopurifier® as a potential treatment SAN DIEGO, June 26,
From Vaccines to Therapeutics; How Biotech Is Addressing the Ebola Outbreak
07:00am, Friday, 26'th Jun 2026
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - June 26, 2026) - Investorideas.com, a leading investment platform for retail investors
Aethlon Medical, Inc. (AEMD) Q4 2026 Earnings Call Transcript
07:32pm, Wednesday, 10'th Jun 2026
Aethlon Medical, Inc. (AEMD) Q4 2026 Earnings Call Transcript
Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update
04:15pm, Wednesday, 10'th Jun 2026
Australian oncology study advances into Cohort 3 as enrollment continues Entered the third and final dosing cohort of the Australian oncology study, expanded the Hemopurifier intellectual property por
Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026
08:01am, Tuesday, 02'nd Jun 2026
SAN DIEGO, June 2, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, to
Aethlon Medical Monitoring Current Ebola Outbreak and Reaffirms Outbreak/Pandemic Preparedness
08:01am, Thursday, 21'st May 2026
SAN DIEGO, May 21, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, tod
Advancements in Novel Immunotherapeutics in The Oncology Battle
10:30am, Tuesday, 24'th Mar 2026
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - March 24, 2026) - Investorideas.com, a go-to investing platform, releases an industry
Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review
08:01am, Tuesday, 24'th Mar 2026
SAN DIEGO, March 24, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a clinical-stage biotechnology company developing the investigational Aethlon Hemopurifier®, an extracorporeal device
Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities
08:01am, Thursday, 12'th Mar 2026
SAN DIEGO, March 12, 2026 /PRNewswire/ -- Aethlon Medical, Inc. ("Aethlon" or the "Company") (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-thre
Aethlon Medical to Present at the Life Sciences Investor Forum on March 12th
08:35am, Friday, 06'th Mar 2026
The Company invites individual and institutional investors, as well as advisors and analysts with an interest in the life sciences sector, to attend live, interactive presentations at VirtualInvestorC
Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026
08:01am, Monday, 23'rd Feb 2026
Aethlon invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation on the Emerging Growth Conference. SAN DIEGO, Feb. 23, 2026 /
Aethlon Medical, Inc. (AEMD) Shareholder/Analyst Call Prepared Remarks Transcript
12:25pm, Thursday, 19'th Feb 2026
Aethlon Medical, Inc. (AEMD) Shareholder/Analyst Call Prepared Remarks Transcript
Aethlon Medical, Inc. (AEMD) Q3 2026 Earnings Call Transcript
10:14pm, Thursday, 12'th Feb 2026
Aethlon Medical, Inc. (AEMD) Q3 2026 Earnings Call Transcript
